Edwards Lifesciences (EW)
Builds catheter-based and surgical heart-valve systems led by the SAPIEN TAVR platform.
$88.78
After hours−0.02 (−0.02%)
At close$88.80(+0.52%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,243 | 1,266 | 1,330 | 1,386 | 1,354 | 1,386 | 1,413 | 1,532 | 1,553 | 1,570 | 1,649 | 1,741 |
| Cost of revenue | 272 | 251 | 289 | 298 | 263 | 292 | 302 | 343 | 345 | 341 | 359 | 391 |
| Gross profit | 971 | 1,015 | 1,041 | 1,088 | 1,092 | 1,094 | 1,111 | 1,190 | 1,210 | 1,229 | 1,289 | 1,350 |
| 625 | 659 | 685 | 723 | 741 | 781 | 716 | 759 | 785 | 859 | 775 | 831 | |
| Research & development | 243 | 242 | 257 | 273 | 253 | 271 | 255 | 276 | 281 | 268 | 263 | 279 |
| Selling, general & administrative | 382 | 417 | 428 | 451 | 421 | 492 | 466 | 502 | 515 | 603 | 522 | 561 |
| Other expenses | 0 | 0 | 0 | 0 | 66 | 18 | −4 | −20 | −11 | −12 | −11 | −9 |
| Operating income | 347 | 357 | 356 | 365 | 351 | 313 | 395 | 431 | 425 | 370 | 515 | 520 |
| 41 | 11 | 16 | 22 | 52 | 78 | 39 | −31 | −77 | −280 | −56 | 0 | |
| Interest income | 16 | 17 | 19 | 17 | 24 | 44 | 20 | 37 | 39 | 36 | 34 | 30 |
| Other non-operating income | −41 | −11 | −16 | −22 | −44 | −129 | −39 | 69 | 77 | 280 | 56 | 0 |
| Income before tax | 388 | 367 | 371 | 387 | 403 | 390 | 434 | 400 | 348 | 90 | 459 | 520 |
| Income tax expense | 53 | 34 | 46 | 20 | 41 | 45 | 70 | 64 | 56 | 26 | 78 | 278 |
| Net income from continuing operations | 335 | 333 | 325 | 366 | 362 | 345 | 364 | 336 | 292 | 64 | 381 | 241 |
| Discontinued operations | 49 | 37 | 26 | −1 | 2,707 | 39 | −7 | −4 | −2 | 27 | 0 | 0 |
| Net income | 385 | 370 | 352 | 364 | 3,071 | 386 | 358 | 330 | 291 | 91 | 381 | 242 |
| EPS, basic | $0.63 | $0.61 | $0.58 | $0.61 | $5.14 | $0.65 | $0.61 | $0.57 | $0.50 | $0.16 | $0.66 | $0.42 |
| EPS, diluted | $0.63 | $0.61 | $0.58 | $0.61 | $5.13 | $0.65 | $0.61 | $0.56 | $0.50 | $0.16 | $0.66 | $0.42 |
| Weighted average shares, basic | 607 | 605 | 602 | 602 | 597 | 590 | 587 | 587 | 585 | 580 | 579 | 576 |
| Weighted average shares, diluted | 610 | 607 | 604 | 604 | 598 | 591 | 588 | 588 | 586 | 582 | 581 | 578 |
| EBITDA | 425 | 404 | 410 | 426 | 429 | 484 | 471 | 400 | 388 | 133 | 500 | 520 |
| Depreciation & amortization | 37 | 37 | 39 | 40 | 35 | 43 | 37 | 38 | 39 | 43 | 41 | 0 |
| EBIT | 388 | 367 | 371 | 387 | 394 | 441 | 434 | 362 | 348 | 90 | 459 | 520 |